Bacterial infection results in the production of inflammatory mediators and may be involved in the pathogenesis of sepsis and/or systemic inflammatory response syndrome. The effect of lipopolysaccharide (LPS), a major component of the outer surface of Gram-negative bacteria, and Staphylococcal enterotoxin B (SEB), a superantigen of Gram-positive bacteria, on cytokine production in peripheral blood mononuclear cells (PBMCs) was examined. LPS significantly increased the production of proinflammatory and anti-inflammatory cytokines, and SEB enhanced the production of helper T lymphocyte type cytokines. These results illustrated the different responses to Gram-negative and Gram-positive bacterial infections. The effect of gabexate mesilate, a synthetic protease inhibitor, on cytokine production and expression of the toll-like receptor (TLR) was also examined. The results suggest that gabexate mesilate-induced inhibition of tumour necrosis factor-a (TNF-a) and interleukin-18 (IL-18) production in LPSstimulated PBMCs is due to the inhibition of the nuclear factor-kB activation pathway and/or inhibition of the processing pathway of pro-TNF-a and pro-IL-18, not to downregulation of TLR-2 or TLR-4.
Introduction
Gabexate mesilate, a synthetic protease inhibitor, inhibits various serine proteases, including trypsin, thrombin, activated factor X, kallikrein, activated complements and neutrophil elastase. 1 A protease inhibitor has been shown to be effective in the treatment of pancreatitis 2 and disseminated intravascular coagulation. 3 It has also been demonstrated to prevent endotoxin-induced pulmonary vascular injury and reduce compression-induced spinal-cord injury in rats by inhibiting neutrophil activation through inhibition of the production of tumour necrosis factor-α (TNF-α). 4, 5 In
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addition, we have shown that peri-operative administration of a protease inhibitor could contribute to ameliorating immunosuppression after major surgery. 6 Thus, it is speculated that a protease inhibitor regulates excessive host responses by inhibiting the production of proinflammatory and/or anti-inflammatory cytokines. Lipopolysaccharide (LPS), or endotoxin, is a major component of the outer surface of Gram-negative bacteria, and Staphylococcal enterotoxin B (SEB) is a superantigen of Grampositive bacteria. Both are potent activators of cells of the immune and inflammatory systems, including macrophages, monocytes and endothelial cells, and they contribute to the systemic changes seen in septic shock. 7, 8 In septic shock, such microbial antigens initiate an uncontrolled network of host-derived proinflammatory mediators, which ultimately lead to cardiovascular shock and death. 9 Host organisms have developed a set of receptors that can recognize specific pathogenassociated molecular patterns, 10 -13 and a series of defence mechanisms are subsequently triggered.
The human toll-like receptors (TLRs) are a family of such receptors involved in innate immune recognition and cellular activation in response to bacterial antigens. 14 -23 TLRs are transmembrane proteins containing repeated leucine-rich motifs in their extracellular regions, similar to other pattern recognition proteins of the innate immune system. 24, 25 TLRs also contain an interleukin (IL)-1 receptor in their cytoplasmic domain. Stimulation of TLRs results in activation of nuclear factor-κB (NF-κB) and induction of cytokines and co-stimulatory molecules required for the adaptive immune response. 24 -26 To date, eight mammalian TLR family members (TLR-1 -8) have been identified, but only the ligands for TLR-2 and TLR-4 have been identified. 27 TLR superfamily members are found in many species, and those with known functions are all involved in host responses to injury and infection.
Most notably, members of the TLR superfamily contain not only the receptor and accessory protein for IL-1, but also the IL-18 receptor, 28 its accessory protein and what appears to be the long-sought-after signalling receptor for LPS, TLR-4. This expanding receptor family is therefore giving rise to new discoveries in the areas of host defence, inflammation and the evolution of innate host defence. In the present research, we have examined cytokine production and TLR expressions in peripheral blood mononuclear cells (PBMCs) stimulated by LPS or SEB, and have analysed the different cytokine responses in host defence mechanisms triggered by Gramnegative and Gram-positive bacteria. We have also examined the effect of a protease inhibitor on cytokine production and TLR expression, and the results have led to the elucidation of the mechanism by which a protease inhibitor could attenuate endotoxin-induced tissue injury.
Materials and methods

REAGENTS
Lipopolysaccharide, purified from Escherichia coli, and SEB were purchased from Sigma Chemical Co. Ltd (St Louis, MO, USA). Gabexate mesilate was provided by Ono Pharmaceutical Co. Ltd (Osaka, Japan).
ISOLATION AND CULTURE OF CELLS
Normal PBMCs were obtained from 10 human volunteers after oral informed consent. Peripheral blood (20 -50 ml) was withdrawn from the vein of the forearm. PBMCs were isolated from the buffer coat by centrifugation on a density gradient of Ficoll-Paque (Pharmacia, Uppsala, Sweden). 
CYTOKINE ASSAYS
The PBMCs were cultured with LPS (5 µg/ml) or SEB (10 ng/ml) for 18 h or 72 h at 37 ºC in a humidified atmosphere of 5% CO 2 in air. For the samples used to investigate the role of a protease inhibitor, the PBMCs were incubated with gabexate mesilate (10 -6 M) for 15 min prior to the addition of LPS or SEB. Control samples were incubated with simple conditional medium. After culture, the cell suspensions were transferred into Eppendorf tubes and centrifuged. The cell-free supernatant fractions were assayed for TNF-α, IL-1β, IL-2, IL-6, IL-10, IL-18, interferon-γ (IFN-γ), IL-1 receptor antagonist (IL-1RA) and soluble TNF receptor type II (sTNF-R2) protein. The cytokines were measured using enzyme-linked immunosorbent assay kits (MBL, Nagoya, Japan) employing the multiple antibodies sandwich principle. All experiments were performed at least in triplicate.
REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION ANALYSIS
Total RNA was extracted from the PBMCs using a Qiagen kit (Valencia, CA, USA) in compliance with the manufacturer's instructions, and was treated with RNase-free DNase I. For the reverse transcriptase (RT) reaction, the MMLV pre-amplification system (Life Technologies, Inc., Rockville, MD, USA) was applied. Polymerase chain reaction (PCR) amplification was performed with Taq gold polymerase (Perkin Elmer, Foster City, CA, USA) for 32 cycles at 95 ºC for 45 s, 54 ºC for 45 s and 72 ºC for 1 min. The oligonucleotide primers used for RT-PCR were: TLR-2, 5′-GCCAAAGTCTTGATT GATTGG and 5′-TTGAAGTT CTCCAGCTCCTG; and for TLR-4, 5′-TGGATACGTTTCCTTA TAAG and 5′-GAAATGGAGGCACCCCTTC. 27 Glyceraldehyde-3-phosphate dehydrogenase primers were obtained from CLONTECH (Palo Alto, CA, USA).
STATISTICAL ANALYSIS
Statistical significance was evaluated using analysis of variance (ANOVA) followed by Student's two-tailed t-test. Values of P < 0.05 were considered to be statistically significant.
Results
PROINFLAMMATORY CYTOKINES
The presence of LPS significantly increased the release of TNF-α, IL-1β and IL-6 from human PBMCs after culture for 18 h and 72 h (P < 0.05). In contrast, SEB did not increase the production of these cytokines at either 18 h or 72 h. The addition of gabexate mesilate significantly decreased the production of TNF-α at 18 h in LPS-stimulated PBMCs (P < 0.05); however, this inhibitory effect was not observed at 72 h. No significant effect of gabexate mesilate was observed on the production of IL-1β and IL-6 in LPS-stimulated PBMCs or on the production of TNF-α, IL-1β and IL-6 in SEB-stimulated PBMCs (Fig. 1) .
ANTI-INFLAMMATORY CYTOKINES
The presence of LPS significantly increased the release of IL-1RA, IL-10 and sTNF-R2 from human PBMCs after culture for 18 h and 72 h (P < 0.05). In contrast, SEB did not increase the production of these cytokines at either 18 h or 72 h. Gabexate mesilate did H Iwadou, Y Morimoto, H Iwagaki et al. Cytokine response in host defence mechanisms not affect the production of these anti-inflammatory cytokines in LPS-or SEBstimulated PBMCs (Fig. 2) .
HELPER T LYMPHOCYTE TYPE CYTOKINES
The presence of LPS significantly increased the release of IL-18 and IFN-γ from human PBMCs after culture for 72 h (P < 0.05), but not after 18 h. In contrast, LPS did not increase IL-2 production at either 18 h or 72 h. SEB significantly increased IL-2 production at 18 h and 72 h (P < 0.05), and IFN-γ production at 72 h; however, SEB had no effect on IL-18 production. Gabexate mesilate significantly decreased IL-18 production at 72 h in LPS-stimulated PBMCs (P < 0.05), but had no effect on the LPS-stimulated IL-2 production and SEBstimulated IL-2, IL-18 and IFN-γ production (Fig. 3) .
EXPRESSION OF HUMAN TLR-2 AND TLR-4 mRNA
Reverse transcriptase-polymerase chain reaction analysis revealed that TLR-2, but not TLR-4, expression was detected at 18 h in unstimulated PBMCs. However, TLR-4 expression was observed at 72 h in unstimulated PBMCs. The addition of LPS or SEB did not up-regulate either TLR-2 or TLR-4 expression. 
Cytokine response in host defence mechanisms
Gabexate mesilate did not down-regulate either TLR-2 or TLR-4 expression in LPS-or SEB-stimulated PBMCs (Fig. 4) .
Discussion
The activation of LPS-responsive cells occurs 
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Staphylococcal enterotoxin B is a superantigen that simultaneously binds certain Vβ chains of the T-cell receptor on CD4 + or CD8 + T cells, and the major histocompatibility class II complex on antigen-presenting cells. 30 Even when present in picogram amounts, it can bind and activate such T cells, resulting in the proliferation and production of IFN-γ, and cytotoxic activity. 31, 32 This research has shown that SEB significantly increased the production of IL-2 and IFN-γ, consistent with earlier work, but did not increase the production of IL-18. In contrast, LPS significantly increased IL-18 and IFN-γ productions, but did not increase IL-2 production. IL-18 is a potent inducer of IFN-γ, 33 and therefore, LPS-induced IFN-γ production was attributable, at least in part, to LPS-induced IL-18. Thus, the cytokine responses to LPS and SEB are not the same, suggesting that host responses to Gramnegative and Gram-positive bacterial antigens are regulated differently. Evidence from in vitro studies indicates that the expression of TLR-2 and TLR-4, two members of the TLR family of cell-surface proteins, can activate NF-κB, the nuclear factor for the κ chain gene in B cells, and the expression of genes for various cytokines. 14, 26 LPS initiates multiple intracellular signalling events, including the stimulation of pathways that lead to the activation of NF-κB and three distinct mitogen-activated protein (MAP) kinases, the ERK, p38 and JNK proteins. 34 TLR-4-mediated NF-κB activation is thought to occur via a signalling pathway that is also utilized by IL-1 and IL-18. This pathway is activated by the interaction between myeloid differentiation protein and the receptor, followed by stimulation of IL-1 receptor-associated kinase and subsequent recruitment of TNF receptor-associated factor-6. Stimulation of these proximal signalling molecules results in the activation of members of the MAP-kinase-kinase-kinase family that activate inhibitory κB (IκB) kinases. 35 IκB kinases can then phosphorylate IκB proteins that retain the rel-type transcription factor NF-κB in the cytosol, leading to ubiquitination and degradation of IκB proteins by the 26 S proteosome, followed by release and nuclear translocation of NF-κB. 36 Gabexate mesilate, a synthetic protease inhibitor, has been shown to significantly decrease the production of TNF-α and IL-18 in LPS-stimulated PBMCs. The inhibitory effects of gabexate mesilate are, at least in part, attributable to its potent inhibition of NF-κB activation by inhibiting the degradation of IκB proteins. Previous work has demonstrated that TNF-α and IL-18 are synthesized as precursor proteins, which are then processed into mature forms by metalloproteinase 37, 38 and caspase-1, 39, 40 respectively. Therefore, a defect in cytokine maturation can also lead to a significant decrease in cytokine production by gabexate mesilate (Fig. 5) . As gabexate mesilate did not down-regulate the expression of TLR-2 or TLR-4 in LPS-stimulated PBMCs, the inhibitory effect of gabexate mesilate on the production of TNF-α and IL-18 was not due to the down-regulation of TLR-2/TLR-4. Thus, the inhibitory effect is suggested to be a defect in the LPS-initiated intracellular signalling pathway.
In conclusion, LPS and SEB showed completely different patterns of cytokine production, illustrating differential regulation in the host responses to Gram-negative and Gram-positive bacterial infections. We also demonstrated that gabexate mesilate, a synthetic protease inhibitor, significantly decreased TNF-α and IL-18 productions in LPS-stimulated PBMCs, probably through inhibition of NF-κB activation and cytokine H Iwadou, Y Morimoto, H Iwagaki et al. Cytokine response in host defence mechanisms maturation pathways. TNF-α is important in mediating LPS-induced pulmonary vascular injury via a direct action on the endothelial cells 41 or through the activation of neutrophils. 42 IL-18 has also been implicated in many pathological conditions, including the host defence against fungal and bacterial infection 43, 44 and Propiobacterium acnesprimed LPS-induced hepatitis. 45 Through the inhibition of cytokine production, a protease inhibitor may be effective in preventing and ameliorating pathological conditions.
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